INVO Fertility, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
INVO Fertility, Inc. (IVF) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period of 143.17 thousand shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod · last filed 2023-04-17
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2022-12-31 was 6.67K shares, a 94.89% decline year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2022-09-30 was 35.67K shares, a 44.50% increase year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2022-06-30 was 24.00K shares, a 6.03% decline year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2022-03-31 was 76.84K shares, a 214.34% increase year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2022 was 143.17K shares, a 30.17% decline from fiscal 2021.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2021 was 205.03K shares, a 220.26% increase from fiscal 2020.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2020 was 64.02K shares, a 2973.50% increase from fiscal 2019.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2019 was 2.08K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | 6.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | 42.33K shares derived: sum of 2 quarters · filed 2023-04-17 | 66.33K shares derived: sum of 3 quarters · filed 2023-04-17 | 143.17K shares 10-K · filed 2023-04-17 | |
| 2022-09-30 | 35.67K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 59.67K shares derived: sum of 2 quarters · filed 2022-11-14 | 136.51K shares 10-Q · filed 2022-11-14 | 266.87K shares derived: sum of 4 quarters · filed 2022-11-14 | |
| 2022-06-30 | 24.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 100.84K shares 10-Q · filed 2022-08-15 | 231.20K shares derived: sum of 3 quarters · filed 2022-08-15 | 255.89K shares derived: sum of 4 quarters · filed 2022-08-15 | |
| 2022-03-31 | 76.84K shares 10-Q · filed 2022-05-16 | 207.20K shares derived: sum of 2 quarters · filed 2022-05-16 | 231.89K shares derived: sum of 3 quarters · filed 2022-05-16 | 257.43K shares derived: sum of 4 quarters · filed 2022-05-16 | |
| 2021-12-31 | 130.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 155.04K shares derived: sum of 2 quarters · filed 2022-03-31 | 180.59K shares derived: sum of 3 quarters · filed 2022-03-31 | 205.03K shares 10-K · filed 2022-03-31 | |
| 2021-09-30 | 24.68K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 50.22K shares derived: sum of 2 quarters · filed 2021-11-15 | 74.67K shares 10-Q · filed 2021-11-15 | 87.82K shares derived: sum of 4 quarters · filed 2021-11-15 | |
| 2021-06-30 | 25.54K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 49.99K shares 10-Q · filed 2021-08-16 | 63.14K shares derived: sum of 3 quarters · filed 2021-08-16 | 46.05K shares derived: sum of 4 quarters · filed 2021-08-16 | |
| 2021-03-31 | 24.45K shares 10-Q · filed 2021-05-17 | 37.59K shares derived: sum of 2 quarters · filed 2021-05-17 | 20.51K shares derived: sum of 3 quarters · filed 2021-05-17 | -1.07M shares derived: sum of 4 quarters · filed 2021-05-17 | |
| 2020-12-31 | 13.15K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -3.94K shares derived: sum of 2 quarters · filed 2021-03-30 | -1.09M shares derived: sum of 3 quarters · filed 2021-03-30 | 64.02K shares 10-K · filed 2021-03-30 | |
| 2020-09-30 | -17.09K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -1.11M shares derived: sum of 2 quarters · filed 2020-11-16 | 50.87K shares 10-Q · filed 2020-11-16 | ||
| 2020-06-30 | -1.09M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | 67.96K shares 10-Q · filed 2020-08-13 | |||
| 2020-03-31 | 1.16M shares 10-Q · filed 2020-05-15 | ||||
| 2019-12-31 | 2.08K shares 10-K · filed 2021-03-30 | 66.67K shares 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |